Skip to main content

Table 2 A set of 61 GBM specimens for analyses of patient survival and the correlation between FABP7 and EGFR expression

From: Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma

Case # Diagnosis Age Survival (wk) Censor FABP7 Nu FABP7 Cyto New Category* EGFR IHC P53 IHC MIB-1
160 GBM 29 253 1 0 0 0 0 0 16.3
381 GBM 32 220 1 0 0 0 0 3 32.6
259 GBM 35 412 1 0 2 0 0 3 5.9
495 GBM 38 125 1 0 2 0 0 3 2.2
262 GBM 39 75.571 1 0 1 0 0 3 12.7
322 GBM 40 33.571 1 0 0 0 0 3 14.7
483 GBM 41 18.4286 1 0 1 0 0 1 6.2
499 GBM 43 26.143 1 0 0 1 2 1 10.8
198 GBM 43 83 1 0 1 0 0 3 32.7
310 GBM 43 66.143 1 0 2 0 0 0 33.6
307 GBM 44 65.4286 1 0 1 0 0 3 29.1
497 GBM 44 138.429 1 0 1 0 0 0 62.1
436 GBM 45 151.286 1 0 0 0 0 1 6.6
212 GBM 46 106.571 1 0 0 0 0 2 39.6
208 GBM 49 68.429 1 0 1 0 0 1 23.1
8 GBM 52 45.429 1 0 2 1 1 1 5.9
501 GBM 53 115.571 1 0 0 0 0 3 47.5
330 GBM 53 20.7143 1 0 1 0 0 2 36.5
446 GBM 56 41.571 1 0 0 0 0 3 39.2
404 GBM 56 68.857 1 0 2 0 0 3 36.1
288 GBM 57 38.2 1 0 0 1 1 2 21.8
19 GBM 58 80.429 1 0 2 0 0 3 6.1
292 GBM 58 38.2 1 0 2 NA NA 0 NA
472 GBM 60 36.714 1 0 0 0 0 0 52.6
286 GBM 61 51.286 1 0 2 0 0 1 51.3
341 GBM 61 39.286 1 0 2 0 0 3 75.2
135 GBM 63 21.143 1 0 2 0 0 1 44.6
494 GBM 63 47.2 1 0 2 1 1 NA NA
426 GBM 64 83.143 1 0 2 0 0 3 34.6
295 GBM 65 58.429 1 0 2 0 0 3 22.1
260 GBM 67 22.5 1 0 0 NA NA 0 11.7
329 GBM 67 58.5 1 0 2 NA NA NA NA
321 GBM 69 24.571 1 0 0 0 0 1 46.9
298 GBM 72 22.429 1 0 0 0 0 1 27.5
309 GBM 76 29.429 1 0 0 0 0 1 91.9
409 GBM 15 149.714 1 1 2 2 0 3 25.4
254 GBM 25 101.571 1 1 2 2 0 3 34.8
403 GBM 35 58 1 1 2 2 0 1 37.9
192 GBM 51 36 1 1 1 2 0 1 31.7
240 GBM 53 8.143 1 1 2 2 0 3 49.2
124 GBM 54 46.143 1 1 2 2 0 1 41.7
470 GBM 56 81 1 1 2 NA NA 0 35.5
408 GBM 57 44 1 1 1 2 0 1 32.8
425 GBM 57 15.143 1 1 1 3 1 1 31.3
279 GBM 59 47.143 1 1 2 3 1 2 23.4
493 GBM 68 49.5 1 1 2 NA NA NA NA
471 GBM 70 42.286 1 1 1 3 2 0 25.5
496 GBM 70 55.857 1 1 1 3 2 0 21.8
245 GBM 70 22.5 1 1 2 NA NA 2 22
241 GBM 32 33.143 1 2 0 2 0 3 25.6
261 GBM 33 21.571 1 2 2 2 0 2 50.1
297 GBM 43 107.571 1 2 2 3 1 2 32.9
323 GBM 46 81 1 2 2 2 0 1 16.9
263 GBM 47 33.286 1 2 2 3 2 3 17.8
90 GBM 48 66.857 1 2 1 3 2 1 15.4
230 GBM 50 17.714 1 2 2 2 0 1 35.8
227 GBM 52 53.1429 1 2 2 3 1 1 43.1
325 GBM 52 32.143 1 2 2 3 2 0 20.3
443 GBM 55 59.286 1 2 1 3 2 1 39.7
296 GBM 59 39 1 2 0 2 0 1 44.9
335 GBM 75 18.143 1 2 2 2 0 1 27.5
  1. *Based on nuclear FABP7 and EGFR immunoreactivity: dual negative as "0", nuclear FABP7-/EGFR+ as "1", nuclear FABP7+/EGFR- as "2", and dual positive as "3"
  2. NA, no IHC data available.